Trial intelligence / Profile preview

Desloratadine in Chronic Idiopathic Urticaria

NCT00795522Phase 4Completed

Sponsor
Organon & Co.
Start
Jul 2003
Primary completion
Feb 2005
Modality
Small Molecules
01

Overview

A Phase 4 trial of desloratadine in chronic idiopathic urticaria (CIU), sponsored by Organon & Co.. Started Jul 2003; status: completed.

02

Drugs

desloratadine
03

Conditions

chronic idiopathic urticaria (CIU)

Beyond the preview

Go deeper on NCT00795522.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00795522.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call